What is the optimal non‑pharmacologic psychological intervention for an 85‑year‑old patient with possible dementia who is restless in bed and appears anxious?

Non-Pharmacologic Interventions for Restlessness and Anxiety in Dementia

For an 85-year-old with possible dementia experiencing restlessness in bed and anxiety, implement person-centered non-pharmacological interventions as first-line treatment, specifically one-on-one social interaction, music therapy, and hand massage, which show the strongest evidence for reducing agitation and anxiety in this population.

Why Non-Pharmacologic Interventions First

Multiple expert guidelines explicitly recommend non-pharmacological approaches as the preferred first-line treatment for neuropsychiatric symptoms in dementia, including anxiety and restlessness 1. This recommendation comes from the American Geriatrics Society, American Psychiatric Society, and American Association for Geriatric Psychiatry. The rationale is clear: psychotropic medications show only modest efficacy while carrying significant risks including increased mortality in elderly dementia patients 1.

Specific Interventions with Strongest Evidence

Based on the most recent meta-analyses, the following interventions demonstrate measurable effectiveness:

Highest Impact Interventions (in order of evidence strength):

• One-on-one social interaction: Consistently rated as having the highest impact on behavioral symptoms across multiple studies 2
• Music therapy: Shows small but consistent reductions in anxiety (SMD -0.21) and agitation 3, and was among the most utilized and effective interventions 2
• Hand massage/touch therapy: Demonstrates high impact on behavioral symptoms and is specifically effective for anxiety reduction 3, 2

Secondary Effective Options:

• Person-centered care approaches: Significantly reduce overall agitation (SMD -0.48), with particular effectiveness for verbal agitation 4
• Simulated social interventions: Including respite videos or lifelike dolls, frequently utilized with good acceptance 2

Implementation Algorithm

Step 1: Immediate bedside interventions (within minutes)

• Initiate calm, one-on-one interaction with the patient
• Play familiar, calming music (patient's preferred genre if known)
• Offer gentle hand massage or therapeutic touch

Step 2: Environmental assessment (concurrent)

• Check for physical discomfort: pain, full bladder, hunger, temperature
• Reduce environmental stimulation: dim lights, minimize noise
• Ensure familiar objects are visible if available

Step 3: Sustained intervention (15-30 minutes)

• Continue the intervention showing the best initial response
• If restlessness persists, try alternative approaches from the high-impact list
• Document which intervention was most effective for future reference

Evidence Quality and Effect Sizes

The evidence shows moderate certainty for anxiety and agitation outcomes 3. While effect sizes are modest (SMD around -0.20 to -0.25), these represent clinically meaningful improvements without the risks associated with pharmacological interventions 3. Recent umbrella reviews from 2026 synthesizing 147 randomized controlled trials confirm consistent small-to-moderate benefits across multiple non-pharmacological modalities 3.

Critical Caveats

Timing matters: Most studies show benefits during or immediately after interventions, with limited evidence for sustained effects beyond the intervention period 5. This means interventions may need to be repeated or maintained rather than being one-time solutions.

Heterogeneity exists: There is substantial variation in individual response, particularly for physical agitation subtypes 4. If initial interventions fail, systematically try alternatives rather than abandoning the non-pharmacological approach.

Acute hospital settings: Recent evidence specifically supports feasibility and effectiveness of these interventions even in pressured acute care environments 5, making them practical for bedside implementation.

When to Escalate

Reserve pharmacological intervention only for situations involving imminent danger or when safety is compromised after systematic trial of non-pharmacological approaches 1. The standard of care supports this stepped approach, with medications as adjuncts rather than first-line treatment for behavioral symptoms in dementia.